Regarded Solutions
Portfolio strategy

Galena Biopharma: Direct Answers From The CEO Crystallize The Strong Potential For Shareholders

One of the remarkable ways that Seeking Alpha has been able to add value for subscribers, comes from the Small Cap Insight articles being generated by many top notch contributors. There are also times when the CEO of a particular company reads our articles and decides to get personally involved.

This was just the case after I wrote this article six weeks ago, about Galena Biopharma (NASDAQ:GALE). About a month after having that article published, I was contacted by Claire Sojda of the Life Science Group of Tiberend Strategic Advisors, Inc. giving me (Regarded Solutions), and Seeking Alpha an opportunity to an exclusive interview with the CEO of Galena, Mark Ahn, which would enable SA...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details